Access Consortium regulators pledge support to tackle COVID-19
Australia, Canada, Singapore, Switzerland, United Kingdom
The Access Consortium regulatory authorities have pledged their collective support in countering the COVID-19 global pandemic
Published
Related content
-
Access strategic plan: Updated for 2025-2028
The updated plan emphasises solidifying our collaborative processes, aligning expectations with industry, and improving our communication strategies. -
International work-sharing - First medicines approved by all five Access Consortium regulators
TGA approves asciminib and faricimab through the Access New Active Substance Work-Sharing Initiative -
The ACSS Consortium welcomes the UK as its newest member
The heads of the Australia-Canada-Singapore-Switzerland (ACSS) Consortium are pleased to announce that the MHRA is joining as a new member